Joan Prat

1.4k total citations
27 papers, 1.0k citations indexed

About

Joan Prat is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Joan Prat has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Biochemistry, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Joan Prat's work include Advanced Glycation End Products research (14 papers), Mitochondrial Function and Pathology (3 papers) and Diet, Metabolism, and Disease (3 papers). Joan Prat is often cited by papers focused on Advanced Glycation End Products research (14 papers), Mitochondrial Function and Pathology (3 papers) and Diet, Metabolism, and Disease (3 papers). Joan Prat collaborates with scholars based in Spain, United States and Italy. Joan Prat's co-authors include Reinald Pamplona, Manuel Portero-Otı́n, Marı́a Josep Bellmunt, Victòria Ayala, Esther Dalfó, Isidró Ferrer, Gustavo Barja, Cristina Ruíz‐Romero, Mariona Jové and José C. E. Serrano and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

Joan Prat

25 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Prat Spain 14 394 382 249 155 114 27 1.0k
Aleardo Koverech Italy 16 207 0.5× 374 1.0× 168 0.7× 76 0.5× 25 0.2× 19 1.1k
Lidia de Bari Italy 26 350 0.9× 959 2.5× 229 0.9× 73 0.5× 84 0.7× 39 1.6k
Consuelo Santa‐María Spain 20 296 0.8× 442 1.2× 82 0.3× 90 0.6× 59 0.5× 47 1.3k
E. Bergamini Italy 24 474 1.2× 616 1.6× 88 0.4× 172 1.1× 71 0.6× 89 1.7k
Victoria Chagoya de Sánchez Mexico 22 195 0.5× 594 1.6× 77 0.3× 82 0.5× 169 1.5× 86 1.5k
Sanjib Guha United States 8 208 0.5× 213 0.6× 251 1.0× 132 0.9× 49 0.4× 13 662
Esther Piltcher Haber Israel 12 466 1.2× 422 1.1× 84 0.3× 297 1.9× 35 0.3× 15 1.2k
Laura Tedesco Italy 14 1.2k 2.9× 869 2.3× 82 0.3× 139 0.9× 97 0.9× 21 2.0k
Katarzyna Winiarska Poland 15 168 0.4× 192 0.5× 103 0.4× 109 0.7× 46 0.4× 34 710
Laura Martínez-Gili Spain 19 377 1.0× 670 1.8× 64 0.3× 164 1.1× 92 0.8× 34 1.6k

Countries citing papers authored by Joan Prat

Since Specialization
Citations

This map shows the geographic impact of Joan Prat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Prat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Prat more than expected).

Fields of papers citing papers by Joan Prat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Prat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Prat. The network helps show where Joan Prat may publish in the future.

Co-authorship network of co-authors of Joan Prat

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Prat. A scholar is included among the top collaborators of Joan Prat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Prat. Joan Prat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torres, Pascual, Omar Ramírez‐Núñez, Meritxell Martin‐Garí, et al.. (2025). Non-enzymatic modification of aminophospholipids induces angiogenesis, inflammation, and insulin signaling dysregulation in human renal glomerular endothelial cells in vitro. Free Radical Biology and Medicine. 235. 15–24.
2.
Muñoz‐Vendrell, Albert, et al.. (2025). False nonresponders to anti‐calcitonin gene‐related peptide monoclonal antibodies: A real‐world analysis beyond migraine frequency reduction. Headache The Journal of Head and Face Pain. 66(1). 172–182.
3.
Muñoz‐Vendrell, Albert, et al.. (2023). Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases. Headache The Journal of Head and Face Pain. 63(4). 559–564. 7 indexed citations
4.
5.
Jové, Mariona, Reinald Pamplona, Joan Prat, Lluı́s Arola, & Manuel Portero-Otı́n. (2013). Atherosclerosis prevention by nutritional factors: A meta-analysis in small animal models. Nutrition Metabolism and Cardiovascular Diseases. 23(2). 84–93. 10 indexed citations
6.
Jové, Mariona, Daniel Cacabelos, Jordi Boada, et al.. (2012). Plant-Derived Phenolics Inhibit the Accrual of Structurally Characterised Protein and Lipid Oxidative Modifications. PLoS ONE. 7(8). e43308–e43308. 9 indexed citations
7.
Philipone, Elizabeth, et al.. (2011). Solitary Orbital Myofibroma: Clinical, Radiographic, and Histopathologic Findings. A Report of Two Cases. Orbit. 30(4). 180–182. 5 indexed citations
8.
Rauw, Wendy M., Dolores Corella, J. Soler, et al.. (2007). Behaviour influences cholesterol plasma levels in a pig model. animal. 1(6). 865–871. 23 indexed citations
9.
Pamplona, Reinald, Esther Dalfó, Victòria Ayala, et al.. (2005). Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation. Journal of Biological Chemistry. 280(22). 21522–21530. 234 indexed citations
10.
Gómez‐Arbonés, Xavier, et al.. (2004). Short CommunicationsA cardiological web as an adjunct to medical teaching: prospective analysis. Medical Teacher. 26(2). 187–189. 5 indexed citations
11.
Diener, HC, Gennaro Bussone, A. Eikermann, et al.. (2004). Placebo-Controlled Comparison of Effervescent Acetylsalicylic Acid, Sumatriptan and Ibuprofen in the Treatment of Migraine Attacks. Cephalalgia. 24(11). 947–954. 79 indexed citations
12.
Portero-Otı́n, Manuel, Reinald Pamplona, Marı́a Josep Bellmunt, et al.. (2002). Advanced Glycation End Product Precursors Impair Epidermal Growth Factor Receptor Signaling. Diabetes. 51(5). 1535–1542. 74 indexed citations
13.
Pamplona, Reinald, Jesús R. Requena, Manuel Portero-Otı́n, et al.. (1998). Carboxymethylated phosphatidylethanolamine in mitochondrial membranes of mammals. European Journal of Biochemistry. 255(3). 685–689. 30 indexed citations
14.
Portero-Otı́n, Manuel, et al.. (1997). Glycaemic control and in vivo non‐oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients. European Journal of Clinical Investigation. 27(9). 767–773. 15 indexed citations
15.
Portero-Otı́n, Manuel, et al.. (1996). Urinary pyrraline as a biochemical marker of non-oxidative maillard reactions in vivo. Life Sciences. 60(4-5). 279–287. 20 indexed citations
16.
Bellmunt, Marı́a Josep, Manuel Portero-Otı́n, Reinald Pamplona, et al.. (1995). Evidence for the Maillard reaction in rat lung collagen and its relationship with solubility and age. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1272(1). 53–60. 30 indexed citations
17.
Bellmunt, Marı́a Josep, et al.. (1995). Age-related fluorescence in rat lung collagen. Lung. 173(3). 177–85. 28 indexed citations
18.
Pamplona, Reinald, et al.. (1995). Chromatographic evidence for amadori product formation in rat liver aminophospholipids. Life Sciences. 57(9). 873–879. 42 indexed citations
19.
Pamplona, Reinald, et al.. (1993). Mechanisms of glycation in atherogenesis. Medical Hypotheses. 40(3). 174–181. 9 indexed citations
20.
Prat, Joan, et al.. (1989). Correlation of plasma lipid fractions with colorimetrically determined glycated hemoglobin in a nondiabetic population. Metabolism. 38(12). 1147–1153. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aleardo Koverech Breakdown of academic impact, for papers by Lidia de Bari Breakdown of academic impact, for papers by Consuelo Santa‐María Breakdown of academic impact, for papers by E. Bergamini Breakdown of academic impact, for papers by Victoria Chagoya de Sánchez Breakdown of academic impact, for papers by Sanjib Guha Breakdown of academic impact, for papers by Esther Piltcher Haber Breakdown of academic impact, for papers by Laura Tedesco Breakdown of academic impact, for papers by Katarzyna Winiarska Breakdown of academic impact, for papers by Laura Martínez-Gili
Rankless by CCL
2026